Thursday, August 13, 2026

ENHYPEN Teases Fans with Mysterious Album Logo and Sound

ENHYPEN announces their second studio album repackage, "ROMANCE: UNTOLD—daydream," set for release on November 11. Pre-orders are open!

March 15, 44 BC: The Day Caesar Was Stabbed and Rome Changed Forever

Julius Caesar's assassination in 44 BC marked the fall of the Roman Republic and the rise of the Roman Empire, reshaping history.

Kim’s Warning: Military Action Against South Korea Could Be Imminent

Kim Jong Un visited the command center of the Second Army Corps, a military unit situated near the inter-Korean border...

Tag: diagnostics

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

NGeneBio Expands Blood Cancer Diagnostic Panel Supply to Seoul National University Bundang Hospital

NGeneBio expands its blood cancer diagnostic panel supply, achieving strong growth in South Korea and international markets.

Neurophet AQUA AD Plus: The Innovative AI Tool Designated for Public Health in 2026

Neurophet's Alzheimer's treatment solution, Neurophet AQUA AD Plus, gains innovative product status, enhancing public procurement access.

How Samsung’s On-Device AI is Transforming Emergency Ultrasound Diagnostics in 2026

Samsung Medical Center is developing AI ultrasound tech for emergency care, enhancing diagnostics with real-time, on-device capabilities.

GC Cell Showcases Cold Chain Innovations the Spring Symposium of the Korean Society of Laboratory Medicine

GC Cell, GC Green Cross, and GC Genome showcased innovations in diagnostics at the 2023 Spring Symposium, enhancing precision medicine.

Dong-A Chammed Unveils Plans to Enter the In Vitro Diagnostic Blood Coagulation Testing Market

Dong-A Chammed will showcase innovative products at the 2026 Spring Symposium, aiming to expand into blood coagulation testing.

SCL Group Partners with Indonesian Hospital to Expand Into Southeast Asia

SCL Group partners with Indonesia's RSCM Hospital to expand Korean-style precision diagnostics in Southeast Asia, focusing on cancer screening and AI solutions.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

3Billion Partners with Austin: What This Means for Rare Disease Diagnostics in the U.S.

3Billion partners with Austin for a new lab to enhance rare disease diagnostics and expand its U.S. market presence.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.